• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 188 Show All Page 4 of 4
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  222
Citric acid esters of mono- and diglycerides Dec 20, 2007 FDA has no questions
  220
alpha-Glycosyl isoquercitrin Nov 19, 2007 FDA has no questions
  219
Ammonium phosphatide Jun 29, 2007 FDA has no questions
  217
Tailored triglycerides containing approximately 12 percent medium-chain fatty acids Aug 20, 2007 FDA has no questions
  216
Lipase enzyme preparation from Rhizopus oryzae May 18, 2007 FDA has no questions
  212
Phospholipase A2 enzyme preparation from Streptomyces violaceruber expressing a gene encoding phospholipase A2 from the same species Mar 22, 2007 FDA has no questions
  210
Water soluble tomato concentrate Feb 8, 2007 FDA has no questions; some uses may require a color additive listing
  209
L-theanine Feb 5, 2007 FDA has no questions
  207
Barley fiber Dec 19, 2006 FDA has no questions
  194
Carbon monoxide Jan 25, 2012 FDA has no questions
  191
Human lysozyme purified from rice Mar 12, 2010 At the notifier's request, FDA ceased to evaluate this notice
  166
Carbon monoxide Sep 29, 2005 At the notifier's request, FDA ceased to evaluate this notice
  156
Tomato lycopene extract 6 percent, tomato lycopene extract 1.5 percent, and crystallized tomato lycopene extract Feb 7, 2005 FDA has no questions; some uses may require a color additive listing Sep 15, 2010
  150
Glucosamine hydrochloride prepared from chitin obtained from Aspergillus niger Sep 9, 2004 At the notifier's request, FDA ceased to evaluate this notice
  143
Carbon monoxide Jul 29, 2004 FDA has no questions
  139
Cassia gum
   (Resubmission of GRN 51)
May 3, 2004 At the notifier's request, FDA ceased to evaluate this notice
  125
Grape seed extract and grape pomace extract
   (Resubmission of GRN 93)
Aug 18, 2003 FDA has no questions; some uses may require a color additive listing
  109
Tuna oil
   (Resubmission of GRN 97)
Dec 4, 2002 FDA has no questions
  108
Glycerol ester of gum rosin Dec 20, 2002 Notice does not provide a basis for a GRAS determination
  107
Polydextrose Oct 17, 2002 At the notifier's request, FDA ceased to evaluate this notice
  106
Glucose oxidase enzyme preparation from Aspergillus oryzae carrying a gene encoding a glucose oxidase from Aspergillus niger Oct 3, 2002 FDA has no questions
  105
Fish oil concentrate Oct 15, 2002 FDA has no questions
  104
Sucrose acetate isobutyrate Aug 16, 2002 FDA has no questions
  103
Lipase enzyme preparation from Aspergillus oryzae carrying a gene constructed from a modified Thermomyces lanuginosus lipase gene and a portion of the Fusarium oxysporum lipase gene Aug 19, 2002 FDA has no questions
  91
Mycoprotein Jan 7, 2002 FDA has no questions Sep 28, 2023
  81
Lipase from Candida rugosa Feb 7, 2002 FDA has no questions
  78
D-Tagatose Oct 25, 2001 FDA has no questions
  66
Milk thistle extract Apr 23, 2001 Notice does not provide a basis for a GRAS determination
  62
Chlorine dioxide generated from particles (<30μm) composed of sodium polyphosphate, magnesium sulfate, sodium silicate and sodium chlorite that are incorporated into low density polyethylene (LDPE) food-packaging films, at levels not exceeding 17.5 micrograms chlorite/in2 of finished package film. Jun 19, 2001 FDA has no questions Aug 20, 2003
  57
Argon gas Nov 2, 2000 FDA has no questions
  49
Bifidobacterium lactis strain Bb12 and Streptococcus thermophilus strain Th4 Mar 19, 2002 FDA has no questions Nov 28, 2005
  48
Vegetable oil phytosterol esters Nov 27, 2000 FDA has no questions
  16
Menhaden oil Jun 8, 1999 At the notifier's request, FDA ceased to evaluate this notice
  9
Polyglycerol polyricinoleic acid Mar 2, 1999 FDA has no questions
  8
Pectin esterase derived from Aspergillus oryzae carrying a gene encoding pectin esterase from Aspergillus aculeatus Mar 2, 1999 FDA has no questions
  7
ARASCO (arachidonic acid-rich single-cell oil) and DHASCO (docosahexaenoic acid-rich single-cell oil) as sources of the fatty acids ARA (arachidonic acid) and DHA (docosahexaenoic acid) Mar 4, 1999 Notice does not provide a basis for a GRAS determination
  41
  6
Dioctyl sodium sulfosuccinate Dec 28, 1998 FDA has no questions
  5
Tasteless smoke Nov 9, 1998 At the notifier's request, FDA ceased to evaluate this notice
  15

Show All 

jump to page of 4 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-